Skip to main content

PRECISION ONCOLOGY CONGRESS

November 7 & 8, 2024

POET 2024 Agenda

THURSDAY, NOVEMBER 7th
54th Floor, Bow Tower

7:45 AM Registration
8:00 AM – 9:00 AM Continental Breakfast
9:00 AM – 9:40 AM

Welcome Address – Dr. Steven Yip & Dr. Pinaki Bose, POET Congress Co-Chairs

  • Dr. Todd Anderson, Cumming School of Medicine
  • Dr. Jennifer Chan, Charbonneau Cancer Institute
  • Dr. Don Morris, Arthur J.E Child Comprehensive Cancer Centre
9:40 AM – 10:20 AM Chair: Dr. Steven Jones
Somatic Mutations in Ageing and Disease
KEYNOTE SPEAKER – Dr. Peter Campbell, Wellcome Sanger Institute, UK
10:20 AM – 10:35 AM Questions & Answers
10:35 AM – 11:50 AM SESSION 1: Precision Oncology, Clinical Trials & RWE
Chair: Dr. Steven Yip
10:35 AM – 10:55 AM Innovations and Intersections in Oncology Real-World Evidence (RWE) – Dr. Winson Cheung, University of Calgary, AB
10:55 AM – 11:00 AM Questions & Answers
11:00 AM – 11:20 AM Targeting the Tumor Microenvironment of Hodgkin Lymphoma – Dr. Christian Steidl, BC Cancer Research Centre, BC
11:20 AM – 11:25 AM Questions & Answers
11:25 AM – 11:50 AM Coffee Break
11:50 AM – 1:05 PM SESSION 1 Continued
11:50 AM – 12:10 PM Precision Oncology, Clinical Trials & RWE – Dr. Janessa Laskin, University of British Columbia, BC
12:10 PM – 12:15 PM Questions & Answers
12:15 PM – 12:35 PM Lung Cancer and Biomarker Driven Research – Dr. Natasha Leighl, University of Toronto, ON
12:35 PM – 12:40 PM Questions & Answers
12:40 PM – 1:00 PM Evolution and New Trends in Early Drug Development in Oncology – Dr. Quincy Chu, University of Alberta, AB
1:00 PM – 1:05 PM Questions & Answers
1:05 PM – 2:05 PM Lunch
2:10 PM – 3:00 PM SESSION 2: Immuno-Oncology / Cell Therapy
Chair: Dr. Nicolas Jacquelot
2:10 PM –2:30 PM Monitoring Anti-Cancer Immune Responses Through T Cell Receptor Sequencing – Dr. Trevor Pugh, Princess Margaret Cancer Centre, ON
2:30 PM – 2:35 PM Questions & Answers
2:35 PM – 2:55 PM Dissecting Spatial Relationships Within the Tumour Microenvironment for Predictive Value – Dr. Logan Walsh, McGill University, QC
2:55 PM – 3:00 PM Questions & Answers
3:00 PM – 3:20 PM Coffee Break
3:20 PM – 4:35 PM SESSION 2 Continued
3:20 PM – 3:40 PM Tissue-Resident Lymphocytes in Cancer – Dr. Tim Halim, University of Cambridge, UK
3:40 PM – 3:45 PM Questions & Answers
3:45 PM – 4:05 PM ILC2s in Ovarian Health and Disease – Dr. Michele Ardolino, University of Ottawa, ON
4:05 PM – 4:10 PM Questions & Answers
4:10 PM – 4:30 PM Harnessing Type 2 Innate Lymphoid Cells in Cancer – Dr. Nicolas Jacquelot, Arnie Charbonneau Cancer Institute, AB
4:30 PM – 4:35 PM Questions & Answers
4:35 PM – 4:45 PM Day 1 Closing Remarks – Drs. Steven Yip & Pinaki Bose, POET Co-Chairs
4:45 PM – 5:30 PM POET Reception
Sky Garden, 54th Floor, Bow Tower
5:30 PM – 8:20 PM

POET Welcome Dinner

INNOVATION IN PRECISION ONCOLOGY

Co-Chairs Dr. Steven Yip & Dr. Pinaki Bose
Mountain View Room, 54th Floor, Bow Tower

Greetings on Behalf of ACF & Role of Philanthropy in a Publicly Funded Cancer Care System – Wendy Beauchesne, CEO, Alberta Cancer Foundation, AB

Twenty-Five Years in Precision Oncology – Could I Have Been More Inaccurate? – Dr. David Huntsman, Chew Wei Professor of Gynaecologic Oncology, BC

Bold, Brave and Strong: Becoming My Best Self-Advocate – Jocelyn Laidlaw, Journalist & Broadcaster, National Ambassador, Colorectal Cancer Canada, AB

FRIDAY, NOVEMBER 8th
54th Floor, Bow Tower

8:00 AM – 9:00 AM Registration & Continental Breakfast
9:00 AM – 9:05 AM Opening Remarks – Drs. Steven Yip & Pinaki Bose, POET Co-Chairs
9:05 AM – 10:20 AM SESSION 3: Precision Oncology and Artificial Intelligence
Chair: Dr. Omar Khan
9:05 AM – 9:25 AM Multimodal, Generative and Agentic AI for Pathology – Dr. Faisal Mahmood, Harvard Medical School, USA
9:25 AM – 9:30 AM Questions & Answers
9:30 AM – 9:50 AM Can a CT Scan Predict the Future? Leveraging Artificial Intelligence for Prognostication Using Imaging Biomarkers – Dr. Omar Khan, Arthur J.E. Child Comprehensive Cancer Centre, AB
9:50 AM – 9:55 AM Questions & Answers
9:55 AM – 10:15 AM Revolutionizing Cancer Biomarker Discovery with Machine Learning: The Future of Precision Oncology – Dr. Ali Bashashati, University of British Columbia, BC
10:15 AM – 10:20 AM Questions & Answers
10:20 AM – 10:50 AM Coffee Break
10:50 AM – 11:45 AM SESSION 3 Continued:
10:50 AM – 11:10 AM The Current and Future Role of Artificial Intelligence for Lung Cancer Screening and Early Detection – Dr. Matthew Warkentin, University of Calgary, AB
11:10 AM – 11:15 AM Questions & Answers
11:15 AM – 11:35 AM ctDNA Determinants of Resistance to Radioligand Therapy in Prostate Cancer – Dr. Alex Wyatt, Vancouver Prostate Centre, BC
11:35 AM – 11:40 AM Questions & Answers
11:45 AM – 12:45 PM Lunch
12:45 PM – 1:40 PM SESSION 4: Liquid Biopsy and Precision Oncology
Chair: Dr. Pinaki Bose
12:45 PM – 1:05 PM Long Read Sequencing to Characterize Human Cancers and Their Epigenomes – Dr. Steven Jones, Canada’s Michael Smith Genome Centre, BC
1:05 PM – 1:10 PM Questions & Answers
1:10 PM – 1:35 PM Dynamic Risk Stratification in Head & Neck Cancer Using Circulating Tumour DNA – Dr. Scott Bratman, Princess Margaret Cancer Centre, ON
1:35 PM – 1:40 PM Questions & Answers
1:40 PM – 2:10 PM Coffee Break
2:10 PM – 3:25 PM SESSION 4 Continued:
2:10 PM – 2:30 PM Towards Multi-Modal Liquid Biopsies – Dr. Florent Mouliere, Cancer Research UK, UK
2:30 PM – 2:35 PM Questions & Answers
2:35 PM – 2:55 PM Towards ctDNA-Guided Treatment of Bladder Cancer – Dr. Lars Dyrskjøt, Aarhus University Hospital, Denmark
2:55 PM – 3:00 PM Questions & Answers
3:00 PM – 3:20 PM ctDNA for MRD and a Pathway to Cure – Dr. James Hadfield, Cambridge Science Park, UK
3:20 PM – 3:25 PM Questions & Answers
3:25 PM Day 2 Closing Remarks – Drs. Steven Yip & Pinaki Bose, POET Co-Chairs